infectious-diseases

Documents about infectious-diseases

• Modeling spatiotemporal dynamics of spread related to infectious diseases#442529HAL (France)
• The 2024 International Consensus Reference Standard for Urinary Tract Infection (UTI) Research fails in Neurogenic Bladder without UTI symptoms#448088bioRxiv / medRxiv
• Diagnostic Performance and Cost-Effectiveness of BALF mNGS in Older Adults with Pulmonary Infections#456076Springer Nature OA
• Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents#481784ClinicalTrials.gov
• Colonization amplification despite limited in-hospital transmission: A modeling study#13005PLOS
• Molecular Characterization and Clinical Profile of Dengue Virus Serotypes in NS1-Positive Patients: A Cross-sectional Study from Rajkot, Gujarat, India#13896bioRxiv / medRxiv
• High diversity amongst African Treponema pallidum genomes provides a window into global transmission dynamics of syphilis: A genomic epidemiology study#28651bioRxiv / medRxiv
• Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults#121472ClinicalTrials.gov
• Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults#148560ClinicalTrials.gov
• Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases#163585WIPO
• <p>Disease burden of asbestos-related cancers in China.</p>#195597Figshare
• <p>Joinpoint regression of asbestosis in China, 1990–2023.</p>#195605Figshare
• Breath aerosol PCR for detection of lower respiratory tract infections: Evaluation of a non-invasive face mask collector in pneumonia patients#210513bioRxiv / medRxiv
• Oropouche, Dengue, and Chikungunya differential diagnosis. Development and validation of predictive models with surveillance data from Espirito Santo-Brazil.#222360bioRxiv / medRxiv
• First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models#224143Figshare
• First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models#224144Figshare
• Social objectives without social pricing? Evidence of unidirectional effects in microfinance#224149Figshare
• Influence of Both La Nina and Island Isolation During COVID-19 on the Epidemiology of Infectious Diseases in New Caledonia.#236016NCBI PubMed Central
• Bacterial co-infection and antimicrobial use in hospital-attended patients with laboratory-confirmed influenza infection: a systematic review and meta-analysis.#238046bioRxiv / medRxiv
• From invisibility to political power: Policy lessons from a decade of Brazil's Social Forum for Infectious and Neglected Diseases.#244361NCBI PubMed Central
• Role of Artificial Intelligence in Infectious Diseases and Antimicrobial Resistance: A Comprehensive Review on Diagnostic, Treatment, and Prevention Aspects.#255303NCBI PubMed Central
• Henipaviruses at the threshold: preparedness in the era of recurrent spillover#273465Europe PMC
• Anti-aging treatments slow propagation of synucleinopathy by restoring lysosomal function#283914Figshare
• Wastewater Surveillance as an Event Detection System: Outbreak and Peak Detection of SARS-CoV-2 Across 281 U.S. Counties#287268bioRxiv / medRxiv
• Sustained Specific EBOV GP Immunogenicity Five-Years Post-Vaccination: Longitudinal Results from North Kivu and Equateur, Democratic Republic of the Congo#296522bioRxiv / medRxiv
• A Phase I Safety and Immunogenicity Trial of UBI SynVac (HIV-1 MN Octameric V3 Peptide Vaccine)#307307ClinicalTrials.gov
• Robust and sensitive ELISA detection of total and activated PRKN#307754Figshare
• Additional file 2 of Global polio vaccination research in the eradication endgame#314685Figshare
• Additional file 1 of Global polio vaccination research in the eradication endgame#314686Figshare
• Spatiotemporal trends in tuberculosis incidence in Thailand, 2012–2023: a nationwide, province-level analysis#328191Springer Nature OA
• Epidemiological characteristics of anthropophilic and zoophilic dermatophytosis: a 40-year retrospective prevalence study#328192Springer Nature OA
• Promise vs. Proof in Digital Interventions for Antimicrobial Stewardship: A Systematic Review and Meta-Analysis of Randomized Controlled Trials#332434bioRxiv / medRxiv
• Computational and Experimental Antibody Affinity and Diagnostic Accuracy Quantification of SARS-CoV-2 SD2 Major Disulfide Loop Analog#346692bioRxiv / medRxiv
• Influenza HA Ferritin Vaccine, Alone or in Prime-Boost Regimens With an Influenza DNA Vaccine in Healthy Adults#356536ClinicalTrials.gov
• Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults#366644ClinicalTrials.gov
• Efficacy of a Large Language Model Data Extraction System in Evidence Reviews for Emerging Infectious Diseases: A Randomized Crossover Trial.#399790NCBI PubMed Central
• Assessment of the Potential for Cross-Border Transmission of Infectious Diseases via Commercial Air Travel - Shanghai Municipality, China, 2019-2023.#418606NCBI PubMed Central
• Reimagining youth-responsive TB care: Voices and visions from adolescents and young adults who completed TB treatment in Nairobi, Kenya#424136bioRxiv / medRxiv
• Flexible Multiple Imputation of Missing Data in Time-Structured Longitudinal Designs#433174Figshare
• Epidemiology and Spectrum of Imported Infectious Diseases in Children and Adolescents Returning to Europe: A Systematic Review#433219Europe PMC
• Cellular immunity to <i>Streptococcus pneumoniae</i>: implications for vaccine-mediated prevention#442396Figshare
• Clinical manifestations, diagnosis, and management of renal involvement in Fabry disease#451854Figshare
• Body Mass Index Trajectories Among Patients with Drug-Susceptible and Drug-Resistant Tuberculosis in Northwest Ethiopia#456073Springer Nature OA
• Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection#467617ClinicalTrials.gov
• Measuring capacities to advance global health security and bioeconomic development on the African continent#475635Europe PMC
• One health perspectives on the epidemiological features and changing incidence of natural focus and vector-borne infectious diseases in China: An observational trend study#120098Europe PMC
• Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru#148559ClinicalTrials.gov
• Influence of Both La Nina and Island Isolation During COVID-19 on the Epidemiology of Infectious Diseases in New-Caledonia#398892HAL (France)
• A review of drivers of emerging infectious diseases within the wildlife-human-domestic animal interface in the West Pacific Tropics.#30906NCBI PubMed Central
• B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B#67676ClinicalTrials.gov